MENU
+Compare
TGTX
Stock ticker: NASDAQ
AS OF
Jul 10, 04:59 PM (EDT)
Price
$37.67
Change
-$0.25 (-0.66%)
Capitalization
6.02B

TGTX TG Therapeutics Forecast, Technical & Fundamental Analysis

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TGTX with price predictions
Jul 09, 2025

TGTX's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for TGTX moved out of overbought territory on June 10, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 instances where the indicator moved out of the overbought zone. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for TGTX crossed bearishly below the 50-day moving average on June 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TGTX broke above its upper Bollinger Band on June 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where TGTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 09, 2025. You may want to consider a long position or call options on TGTX as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TGTX just turned positive on July 09, 2025. Looking at past instances where TGTX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

TGTX moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TGTX advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where TGTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TGTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.381) is normal, around the industry mean (17.327). P/E Ratio (151.680) is within average values for comparable stocks, (59.374). TGTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.418). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (16.129) is also within normal values, averaging (272.335).

View a ticker or compare two or three
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TGTX is expected to report earnings to rise 540.00% to 19 cents per share on August 05

TG Therapeutics TGTX Stock Earnings Reports
Q2'25
Est.
$0.19
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.07
Q3'24
Est.
$0.02
Q2'24
Beat
by $0.09
The last earnings report on May 05 showed earnings per share of 2 cents, missing the estimate of 15 cents. With 530.48K shares outstanding, the current market capitalization sits at 6.02B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRECX18.85N/A
N/A
PGIM Jennison Blend C
IYSYX18.74N/A
N/A
Macquarie Smid Cap Core Fund Class Y
FSPSX57.15N/A
N/A
Fidelity International Index
SCRLX76.14N/A
N/A
Touchstone Large Cap Focused Instl
EVDAX21.07N/A
N/A
Camelot Event Driven A

TGTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+6.49%
ARRY - TGTX
36%
Loosely correlated
+4.62%
CLLS - TGTX
36%
Loosely correlated
+0.93%
AXON - TGTX
36%
Loosely correlated
+1.98%
ROIV - TGTX
36%
Loosely correlated
+3.31%
CPRX - TGTX
36%
Loosely correlated
+4.22%
More